OverviewChartNewsTraderScreen

Soc. Generale Knock-Out AMGN/  DE000SD4L9V0  /

EUWAX
20/05/2024  11:52:57 Chg.+0.03 Bid12:55:32 Ask12:55:32 Underlying Strike price Expiration date Option type
9.43EUR +0.32% 9.41
Bid Size: 2,000		 9.53
Ask Size: 2,000		 Amgen Inc 211.8404 USD 31/12/2078 Call
TeleTrader 16/05 FDA approves Amgen's small cell lung cancer drug
GlobeNewswire 16/05 CytomX Therapeutics Announces New Employment Inducement Grants
GlobeNewswire 15/05 Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member
GlobeNewswire 14/05 Accumulus Synergy Sponsors Revolutionary Healthcare Data Standard, Advancing Towards Global Dossier
GlobeNewswire 14/05 Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Adv...
GlobeNewswire 13/05 TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 09/05 Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan
GlobeNewswire 09/05 argenx Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 08/05 CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 ...
GlobeNewswire 08/05 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
TeleTrader 08/05 US closes flat to higher with more earnings on the horizon
GlobeNewswire 08/05 Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination ...
GlobeNewswire 07/05 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
TeleTrader 03/05 US closes higher after softer-than-expected jobs print
TeleTrader 03/05 Wall Street surges on open as jobs report sparks rate cut hopes
TeleTrader 03/05 Amgen soars 14% on positive weight-loss drug data
TeleTrader 02/05 Amgen Q1 revenue jumps 22% to $7.4 billion
TeleTrader 02/05 US surges at close as traders weigh Fed remarks
TeleTrader 02/05 US opens higher, Dow jumps 240 points
GlobeNewswire 02/05 Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Canc...
TeleTrader 02/05 US higher premarket after Fed's decision
GlobeNewswire 01/05 Fight Colorectal Cancer Launches ChatCRC: An AI-Powered Chatbot Revolutionizing Colorectal Cancer Su...
GlobeNewswire 01/05 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...
GlobeNewswire 30/04 Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab bios...
GlobeNewswire 24/04 Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeti...